We salute industry experts helping companies survive and sustain in this economic pandemic; they are working day and night to help companies take rapid-decisions by finding
# Covid Impact on Pharmaceutical Excipients Market, growth/decline in product type/use cases of Pharmaceutical Excipients Market due to cascaded impact of Covid on Extended Ecosystem..
# How top 50 companies in Pharmaceutical Excipients Market are making rapid shifts in their strategies as we speak here...
# Outside-in view of top 50 companies client and client’s clients shifting short-term priorities
Factors such as the growing pharmaceuticals industry coupled with advancements in functional excipients, rising adoption of orphan drugs, and increasing uptake of biopharmaceuticals, are driving the market for pharmaceutical excipients. The emergence of multifunctional excipients, shifting the focus of pharmaceutical manufacturing to emerging markets, and the growing Biosimilars industry also present significant growth opportunities for market players in the pharmaceutical excipients market.
Download PDF Brochure@
The pharmaceutical excipients market is projected to reach USD 9.7 billion by 2025 from USD 6.9 billion in 2019, at a CAGR of 5.8%.
The study involved 4 major activities in estimating the current market size for pharmaceutical excipients market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
Recent Developments:
# In April 2019, Colorcon, Inc. (US) signed an agreement with DuPont Nutrition and Biosciences (US) in order to enhance the current product portfolio of CR Alliance products.
# In February 2019, Associated British Foods plc (UK) signed an agreement with Indchem International (India) under which, Indchem will distribute Associated British Food’s functional lipid excipient product line in the Indian market.
# In January 2019, Croda International (UK) acquired Brenntag Biosector (Denmark) for its vaccine adjuvants portfolio which would be complementary to Croda’s pharmaceutical excipients portfolio.
# In December 2018, Roquette Feres (France) signed an agreement with Thermo Fisher Scientific (US), which gives Thermo Fisher the right to distribute the product portfolio of Roquette in the US and Canada.
The Asia Pacific is expected to be the fastest growing the market in 2019
In 2018, the Asia Pacific region was seen as the fastest growing region in the pharmaceutical excipients market. The ease of doing business in the Asia Pacific region in terms of reduced regulatory stringency, reduced raw material & labor costs, and a higher target market make this region the fastest growing market in 2019.
The key players in the global pharmaceutical excipients market are Ashland (US), BASF (Germany), DuPont (US), Roquette (France), Evonik Industries (Germany), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol (US), and Croda International (UK).
Request Sample Pages@
Key Questions Addressed in the Report
# Who are the top 10 players operating in the pharmaceutical excipients market?
# What are the drivers, restraints, opportunities, and challenges in the pharmaceutical excipients market?
# What are the industry trends as well as the current scenario in the pharmaceutical excipients market?
# What are the growth trends in the pharmaceutical excipients market at the segmental and overall market levels?
# How is the pharmaceutical excipients market performing in different regions across the globe?
No comments:
Post a Comment